Cochrane Abstracts
D‐penicillamine for primary sclerosing cholangitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"D‐penicillamine for Primary Sclerosing Cholangitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436121/all/D‐penicillamine_for_primary_sclerosing_cholangitis.
D‐penicillamine for primary sclerosing cholangitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436121/all/D‐penicillamine_for_primary_sclerosing_cholangitis. Accessed December 26, 2024.
D‐penicillamine for primary sclerosing cholangitis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436121/all/D‐penicillamine_for_primary_sclerosing_cholangitis
D‐penicillamine for Primary Sclerosing Cholangitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436121/all/D‐penicillamine_for_primary_sclerosing_cholangitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - D‐penicillamine for primary sclerosing cholangitis
ID - 436121
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436121/all/D‐penicillamine_for_primary_sclerosing_cholangitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
